Kenya BioVax Institute Limited

05/06/2026

04/06/2026

Strengthening regional collaboration remains central to advancing Africa’s health security agenda. was pleased to host the Africa CDC team during a courtesy call to the Institute. The team held productive discussions with the Chief Executive Officer, Dr Wesley Ronoh, and technical team on areas of mutual interest, including local vaccine and biologics manufacturing capacity, technical cooperation, and sustainable access to quality-assured health products.

04/06/2026

Our Service Charter in Sign Language

03/06/2026

Academia, industry and government came together at the Public Lecture and Stakeholder Engagement Forum on “Academia, Industry and the Trigger for Local Manufacturing” to advance Kenya’s local biopharmaceutical manufacturing agenda. Prof. Stephen Gacheru emphasized that beyond research and science, drug development is an end-to-end ecosystem requiring knowledge, regulation, infrastructure, financing and market readiness to work together.

Dr. Ouma Oluga, OGW, Principal Secretary, State Department for Medical Services, h, called for stronger linkage between research, academia, industry, regulation, financing and procurement to strengthen Kenya’s health independence. He further challenged universities to shift from being primarily publication-driven to becoming proprietary and innovation-driven institutions that convert knowledge into products, enterprises and public health solutions. Dr. Charles Githinni, Kenya BioVax Institute Chairman, noted that local manufacturing must be treated as an end-to-end national health security priority, with plans underway for a dedicated symposium to sustain the momentum.

03/06/2026

Advancing Africa’s health security requires stronger coordination between manufacturers, continental institutions, and procurement platforms. In this spirit, the Kenya BioVax team, led by Dr. Cecilia Wanjala, General Manager, Commercial Services, held a stakeholder engagement meeting with the Africa CDC team at the Africa CDC Offices in Nairobi to discuss Africa’s pooled procurement mechanisms. The engagement provided an opportunity to explore how coordinated procurement can improve access to essential health products, support predictable demand, strengthen market pathways for local manufacturers, and contribute to sustainable vaccine and biotherapeutics production across the continent.

01/06/2026

Happy Madaraka Day from Kenya BioVax Institute!

30/05/2026

Kenya BioVax, in collaboration with the University of Nairobi, invites stakeholders to a Public Lecture and Stakeholder Engagement Forum on “Academia, Industry and the Trigger for Local Manufacturing.”

The lecture, delivered by Prof. Stephen Gacheru, will explore the potential for biopharmaceutical manufacturing in Kenya, with Dr. Ouma Oluga, OGW, Principal Secretary, State Department for Medical Services, as Chief Guest.

📅 3rd June 2026
⏰ 2:00 p.m. – 4:00 p.m.
📍 UoN Faculty of Health Sciences, Lecture Theatre 3

30/05/2026

Advancing Kenya’s capacity for vaccine and specialized biologics manufacturing requires strong partnerships, evidence-informed planning, and a clear understanding of market opportunities. In this regard, Kenya BioVax Institute held a meeting with PATH to discuss a proposed vaccine landscape assessment aimed at guiding investment priorities, policy decisions, portfolio diversification, and alignment with global health security goals. The Kenya BioVax team, led by Dr. Muteru, engaged the PATH team led by Ruth Wanjala on the importance of co-creating solutions with end users to ensure that future manufacturing priorities respond to public health needs, market realities, and Kenya’s broader ambition of building sustainable local capacity for vaccines and specialized biologics.

26/05/2026